| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Clinical Neuroendocrinology (J.B., D.S., H.-L.F.), and Department of Internal Medicine (C.D., H.-L.F.), University of Lübeck, 23538 Lübeck, Germany; and Physiological Psychology (J.B.), University of Bamberg, 96045 Bamberg, Germany
Address all correspondence and requests for reprints to: Jan Born, Ph.D., Medizinische Universität Lübeck, Klinische Forschergruppe: Klinische Neuroendokrinologie, Haus 23a, Ratzeburger Allee 160, 23538 Lübeck, Germany.
Pituitary-adrenal activity has been found to be inhibited during early nocturnal sleep in humans. This inhibition was supposed to reflect a regulatory influence of hippocampal cells characterized by the expression of mineralocorticoid receptors (MR). Pituitary adrenal responsiveness to bolus injections of CRH (50 µg) was examined in each of nine healthy men on four occasions: CRH was injected either during early nocturnal sleep or at the same time of night while the subject was kept awake. Both of these conditions were run after pretreatment with the selective MR antagonist, canrenoate (2 x 200 mg, 0800 and 1700 h, preceding the experimental night) and after placebo administration. After placebo, sleep reduced ACTH and cortisol secretory responses to CRH to about 65% of the size observed during wakefulness (P < 0.05). After canrenoate, ACTH and cortisol secretory responses during sleep and wakefulness did not differ and were comparable with those obtained in placebo-treated subjects during wakefulness. Compared with placebo, canrenoate also distinctly reduced the time spent in slow-wave sleep (P < 0.005). The findings confirm an inhibition of pituitary-adrenal responsiveness during early sleep. The inhibition disappearance after blockage of MR suggests that sleep exerts this influence via central nervous MR-expressing cells. These cells seem to be simultaneously involved in the generation of slow-wave sleep.
This article has been cited by other articles:
![]() |
P. Wellhoener, J. Born, H. L. Fehm, and C. Dodt Elevated Resting and Exercise-Induced Cortisol Levels after Mineralocorticoid Receptor Blockade with Canrenoate in Healthy Humans J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5048 - 5052. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chapotot, C. Gronfier, C. Jouny, A. Muzet, and G. Brandenberger Cortisol Secretion Is Related to Electroencephalographic Alertness in Human Subjects during Daytime Wakefulness J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4263 - 4268. [Abstract] [Full Text] |
||||
![]() |
E. A. Young, J. F. Lopez, V. Murphy-Weinberg, S. J. Watson, and H. Akil The Role of Mineralocorticoid Receptors in Hypothalamic-Pituitary-Adrenal Axis Regulation in Humans J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3339 - 3345. [Abstract] [Full Text] |
||||
![]() |
C. Gronfier, F. Chapotot, L. Weibel, C. Jouny, F. Piquard, and G. Brandenberger Pulsatile cortisol secretion and EEG delta waves are controlled by two independent but synchronized generators Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E94 - E100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bierwolf, A. Burgemeister, K. Lüthke, J. Born, and H. L. Fehm Influence of Exogenous Atrial Natriuretic Peptide on the Pituitary-Adrenal Response to Corticotropin-Releasing Hormone and Vasopressin in Healthy Men J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1151 - 1157. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |